Cardium's Generx Advances to Phase 3 Following Meeting With FDA (Exercise treadmill)

Cardium's Generx Advances to Phase 3 Following Meeting With FDA
Cardium Therapeutics, Inc announced that Generx is to be advanced to a Phase 3 clinical trial in women as a potential treatment for myocardial ischemia , following an end-of-Phase 2 meeting with the U.S.
Source: biz.yahoo.com

Yakima just right regardless of price
He might not have won the car, but it was a Yakima booster's dream come true. On Tuesday, during the broadcast of "The Price is Right" television game show, the city of Yakima will practically become a star contestant.
Source: www.yakima-herald.com

Cardium's Generx Advances To Phase 3 Following Meeting With FDA
Cardium Therapeutics, Inc (OTC Bulletin Board: CDTP) announced that Generx(TM) (alferminogene tadenovec) is to be advanced to a Phase 3 clinical trial in women as a potential treatment for myocardial ischemia (insufficient blood flow within the heart muscle), following an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA). [click link for full article]
Source: www.medicalnewstoday.com

Hemispherx Comments on Chronic Fatigue Syndrome Initiatives by the Centers for Disease Control
PHILADELPHIA----Hemispherx, Inc. , a biopharmaceutical firm focused on RNA-based therapeutic solutions for chronic severely debilitating diseases, has today commented on the growing visibility of Chronic Fatigue Syndrome as a serious disease.
Source: biz.yahoo.com